4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 23, 2012

Primary Completion Date

May 27, 2013

Study Completion Date

May 27, 2013

Conditions
Anaemia
Interventions
DRUG

GSK1278863

tablet

DRUG

rhEPO

injection

Trial Locations (62)

11212

GSK Investigational Site, Brooklyn

16507

GSK Investigational Site, Erie

17109

GSK Investigational Site, Demmin

20814

GSK Investigational Site, Bethesda

22297

GSK Investigational Site, Hamburg

27101

GSK Investigational Site, Winston-Salem

27704

GSK Investigational Site, Durham

31217

GSK Investigational Site, Macon

31275

GSK Investigational Site, Lehrte

33028

GSK Investigational Site, Pembroke Pines

33071

GSK Investigational Site, Coral Springs

33145

GSK Investigational Site, Miami

33150

GSK Investigational Site, Miami

34608

GSK Investigational Site, Spring Hill

48195

GSK Investigational Site, Southgate

48236

GSK Investigational Site, Detroit

50937

GSK Investigational Site, Cologne

60031

GSK Investigational Site, Gurnee

60262

GSK Investigational Site, Lynwood

63741

GSK Investigational Site, Aschaffenburg

69120

GSK Investigational Site, Heidelberg

71603

GSK Investigational Site, Pine Bluff

72450

GSK Investigational Site, Paragould

73116

GSK Investigational Site, Oklahoma City

75402

GSK Investigational Site, Greenville

76011

GSK Investigational Site, Arlington

77004

GSK Investigational Site, Houston

77091

GSK Investigational Site, Houston

78229

GSK Investigational Site, San Antonio

80002

GSK Investigational Site, Arvada

80031

GSK Investigational Site, Westminster

80230

GSK Investigational Site, Denver

85284

GSK Investigational Site, Tempe

85764

GSK Investigational Site, Oberschleißheim

89106

GSK Investigational Site, Las Vegas

90022

GSK Investigational Site, Los Angeles

90057

GSK Investigational Site, Los Angeles

90603

GSK Investigational Site, Whittier

91307

GSK Investigational Site, West Hills

91702

GSK Investigational Site, Azusa

92505

GSK Investigational Site, Riverside

92868

GSK Investigational Site, Orange

93308

GSK Investigational Site, Bakersfield

93309

GSK Investigational Site, Bakersfield

90025-4837

GSK Investigational Site, Los Angeles

06708

GSK Investigational Site, Waterbury

NC 28805

GSK Investigational Site, Asheville

Unknown

GSK Investigational Site, Charlotte

TX 76543

GSK Investigational Site, Killeen

T2R 0X7

GSK Investigational Site, Calgary

T6G 2B7

GSK Investigational Site, Edmonton

B3H 1V7

GSK Investigational Site, Halifax

P3E 5J1

GSK Investigational Site, Greater Sudbury

N6A 5A5

GSK Investigational Site, London

DK-9000

GSK Investigational Site, Aalborg

DK-5000

GSK Investigational Site, Odense

DK-4000

GSK Investigational Site, Roskilde

0027

GSK Investigational Site, Oslo

0405

GSK Investigational Site, Oslo

SE-651 85

GSK Investigational Site, Karlstad

SE-141 86

GSK Investigational Site, Stockholm

SE-751 85

GSK Investigational Site, Uppsala

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

PPD Development, LP

INDUSTRY

lead

GlaxoSmithKline

INDUSTRY